Femasys INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
FEMY
Femasys INCFemasys Inc. reported continued operating losses and substantial doubt about its ability to continue as a going concern, alongside Nasdaq delisting notices, despite increased sales and product development progress.
NASDAQ
FEMY
Femasys INC10-K: Femasys Inc. Reports Progress on FemBloc, FemaSeed, and Global Expansion in Annual 10-K Filing
Femasys Inc. highlights advancements in its women's health portfolio, including regulatory approvals and strategic partnerships, in its annual 10-K filing.
NASDAQ
FEMY
Femasys INCFemasys Inc. has filed an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and updated certifications.
NASDAQ
FEMY
Femasys INCFemasys Inc.'s 10-K filing details the company's financial status, product development, and strategic initiatives in women's health, including FemaSeed and FemBloc.